Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison Between Transcranial Stimulation Protocols With Continuous Current in the Chronic Migraine (NEUROMIG)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03414203
Recruitment Status : Completed
First Posted : January 29, 2018
Last Update Posted : August 28, 2019
Sponsor:
Information provided by (Responsible Party):
Renata Emanuela Lyra de Brito Aranha, Federal University of Paraíba

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This study aims to compare the effects of transcranial direct current stimulation on the clinical and cognitive function in patients with chronic migraine.

Condition or disease Intervention/treatment Phase
Chronic Migraine Other: tDCS Not Applicable

Detailed Description:
The patients will be randomized into 1 of 3 groups: active tDCS for 15 minutes, active tDCS for 15 minutes, with an interval of 20 minutes and more 15 minutes os stimulation, sham tDCS for 15 minutes. The tDCS will be applied for 10 days over 2 weeks.
Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 31 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description:

The patients will be randomized into 1 of 3 groups:

group A: active tDCS for 15 minutes, group B: active tDCS for 15 minutes, with an interval of 20 minutes and group C: more 15 minutes os stimulation, sham tDCS for 15 minutes.
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Comparison Between Stimulation Transcranial Protocols With Continuous Current in the Chronic Migraine: Clinical Trial, Triple-blind, Placebo-controlled
Actual Study Start Date : August 14, 2017
Actual Primary Completion Date : February 5, 2018
Actual Study Completion Date : February 16, 2018

Resource links provided by the National Library of Medicine

MedlinePlus Genetics related topics: Migraine
MedlinePlus related topics: Migraine

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Active Comparator: active tDCS
Active tDCS for 15 minutes for 10 days over 2 weeks. Intensity: 2 milliampere. Placement: anode - left DLPFC; cathode - right supraorbital region
 Other: tDCS
Transcranial Current Stimulation equipment consists of an ammeter (measured with current intensity), a potentiometer (voltage controller between the electrodes), a generator (two 9-volt batteries) and two electrodes (anode and cathode). The direct low-amplitude currents released by the electrodes reach the cortex and modify the neuronal potentials.
Experimental: active tDCS with interval
Active tDCS for 15 minutes, interval of 20 minutes and more 15 minutes for 10 days over 2 weeks. Intensity: 2 milliampere. Placement: anode - left DLPFC; cathode - right supraorbital region
 Other: tDCS
Transcranial Current Stimulation equipment consists of an ammeter (measured with current intensity), a potentiometer (voltage controller between the electrodes), a generator (two 9-volt batteries) and two electrodes (anode and cathode). The direct low-amplitude currents released by the electrodes reach the cortex and modify the neuronal potentials.
Sham Comparator: sham tDCS
Sham tDCS for 15 minutes for 10 days over 2 weeks. The stimulation is non-active. Placement: anode - left DLPFC; cathode - right supraorbital region
 Other: tDCS
Transcranial Current Stimulation equipment consists of an ammeter (measured with current intensity), a potentiometer (voltage controller between the electrodes), a generator (two 9-volt batteries) and two electrodes (anode and cathode). The direct low-amplitude currents released by the electrodes reach the cortex and modify the neuronal potentials.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Migraine Disability Assessment - MIDAS [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in perform activities of daily living associate to migraine assessed on the Migraine Disability Assessment - MIDAS.


Secondary Outcome Measures :
  1. Headache Impact Test - HIT-6 [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in quality of life associate to migraine assessed on the Headache Impact Test-6 (HIT-6)

  2. Wechsler Intelligence Scale Letters [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in cognitive ability assessed on the Wechsler Adult Intelligence Scale Letters

  3. Wechsler Intelligence Scale Numbers Test [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in cognitive ability assessed on the Wechsler Adult Intelligence Scale Numbers Test

  4. Hayling's Test Hayling's Test [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in operational memory assessed on the Hayling's Test Evaluate operational memory

  5. Trail Making Test part B [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in executive functions assessed on the Trail Making Test part B

  6. Salthouse Visual Patterns and Lyrics [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in visual processing speed assessed on the Salthouse Visual Patterns and Lyrics

  7. Nine Hole Peg Test [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in the motor processing speed assessed on the Nine Hole Peg Test

  8. Paced Auditory Serial Addition Task [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in selective attention assessed on the Paced Auditory Serial Addition Task

  9. Concentrated Attention Test [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in selective attention assessed on the Concentrated Attention Test

  10. Visual Attention Test (Attention Matrices) [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in selective attention assessed on the Visual Attention Test (Attention Matrices)

  11. Montreal Cognitive Assessment [ Time Frame: "before treatment", "after treatment - up to 2 weeks " and "up to 1 month after the last day of treatment" ]
    Change in cognition assessed on the Montreal Cognitive Assessment

  12. Side Effects Questionnaire [ Time Frame: "every day for up to 2 weeks" ]
    adverse effects assessment


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • females
  • clinical diagnosis of chronic migraine according to the International Classification of Headaches Disorders (ICHD-3 beta).

Exclusion Criteria:

  • headache attributable to some pathological condition, associated neurologic or neuropsychiatric disease
  • use of central nervous system modulating drugs
  • pregnancy
  • metallic head implants
  • use of a cardiac pacemaker
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03414203


Locations
Layout table for location information
Brazil
Federal University of Paraiba
João Pessoa, Paraiba, Brazil
Sponsors and Collaborators
Federal University of Paraíba
Investigators
Layout table for investigator information
Principal Investigator: Renata Aranha Federal University of Paraiba
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Renata Emanuela Lyra de Brito Aranha, researcher, Federal University of Paraíba
ClinicalTrials.gov Identifier: NCT03414203    
Other Study ID Numbers: NEUROMIG
First Posted: January 29, 2018    Key Record Dates
Last Update Posted: August 28, 2019
Last Verified: August 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Renata Emanuela Lyra de Brito Aranha, Federal University of Paraíba:
Transcranial Direct Current Stimulation
Migraine Disorders
Cognitive Symptoms
Additional relevant MeSH terms:
Layout table for MeSH terms
Migraine Disorders
Headache Disorders, Primary
Headache Disorders
 Brain Diseases
Central Nervous System Diseases
Nervous System Diseases